Summary:Using high factor sunscreen compared with low factor sunscreen can decrease the risk of melanoma by 33%, new research demonstrates. Melanoma is the cancer with the strongest increase in incidence in the last decade.
A large study published by the Department of Biostatistics at the University of Oslo in the highly ranked Journal of Clinical Oncology found that using high factor sunscreen compared with low factor sunscreen can decrease the risk of melanoma by 33%.
Using sunscreen does not guarantee protection
In this study sunscreen users reported more sunburn, more sunbathing vacations and use of sunbeds than those who never used sunscreen. As a result non sunscreen users had a lower risk of developing melanoma than those who used low factor sunscreen.
The Department of Biostatistics with the Faculty of Medicine at the University of Oslo have found that sunscreen with an adequate factor can reduce the risk of melanoma by over 30 percent compared with low factor sunscreen.
Melanoma is the cancer with the strongest increase in incidence in the last decade, and the incidence rates have never been as high as in 2014. Now there are about 2,000 new cases of melanoma each year in Norway.
The paradox of sunscreen use
Earlier studies have shown mixed results, some studies found slightly increased risk of melanoma among sunscreen users.
“The explanation for this paradox is that some people use sunscreen to prolong sun exposure and acquire suntan. Moreover, many people don’t apply the proper amount of sunscreen, forget to reapply and missed to apply on all exposed areas resulting in sunburn and increased risk of melanoma,” said Reza Ghiasvand, a PhD candidate at The Department of Biostatistics and a member of the research group “Epidemiological Studies of Lifestyle and Chronic Diseases.” “We found that those who used sunscreen with a factor higher than 15 had a 33% lower risk of melanoma compared with those using sunscreen with a low factor.”
The research group gained access to data from the NOWAC study (https://site.uit.no/nowac/) merged with data from the Cancer Registry of Norway. The study followed over 140,000 Norwegian women for an average of ten years.